12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aciphex Sprinkle delayed-release rabeprazole regulatory update

FDA approved 5 and 10 mg Aciphex Sprinkle delayed-release rabeprazole capsules treat gastroesophageal reflux disease (GERD) for up to 12 weeks in children ages 1-11 years. A 20 mg tablet...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >